Chlamydia pneumoniae infection has been linked to the development of coronary heart disease (CHD), but its relationship to CHD risk factors is less clear. OBJECTIVE: To determine the relationship between past infection with C. pneumoniae and risk factors for CHD, including body weight amongst subjects with and without CHD. METHODS: Antibodies to C. pneumoniae and a range of CHD risk factors were determined in 170 subjects, of whom 43 had recent onset angina. Anthropometric, haemodynamic, lipid and metabolic measurements were obtained and related to antibody status in univariate and multivariate analyses. RESULTS: IgG seropositive (n ¼ 62) did not differ from seronegative subjects in age but were significantly heavier (26.6 AE 0.4 vs 25.5 AE 0.3 kg=m 2 , P ¼ 0.02). The prevalence of seropositivity was similar for subjects with and without CHD and for those with or without hypertension. Subjects with fasting insulin levels greater and those with LDL diameters below the median also had a significantly higher prevalence of seropositivity (45.3 vs 27.3%, P ¼ 0.015 and 45.0 vs 29.4%, P ¼ 0.045 respectively). However in multivariate analysis only body mass index remained significant (P < 0.05). Results were not explained by differences in socioeconomic class. CONCLUSION: Although the study has failed to find a greater prevalence of antibodies to C. pneumoniae amongst subjects with recent onset angina there were associations with a number of cardiovascular risk factors. An increase in body weight appears to underlie these relationships.
Introduction
A number of different lines of evidence have suggested an aetiological role for Chlamydia pneumoniae in the development and clinical presentation of coronary heart disease (CHD). 1 -3 CHD is however a multifactorial disease and a number of major and minor risk factors for its production have been identified. These include elevated serum cholesterol, high blood pressure and cigarette smoking. Diabetic subjects are at particularly high risk of developing CHD and hyper insulinaemia has also been identified as a risk factor. 4, 5 Related abnormalities include central obesity and the presence of small low-density lipoprotein (LDL) particles. 6 The extent to which associations between infection with C. pneumoniae and CHD have been adjusted for the presence of other risk factors has varied amongst the different studies. It is, however, possible that some of the apparent associations between serum positivity for Chlamydia infection and coronary disease may in fact represent associations between Chlamydia infection and other coronary risk factors. 7 -9 In the current study, we have examined serum positivity to C. pneumoniae amongst CHD cases and matched control subjects. While we found no increased prevalence amongst the CHD cases, there were clear associations with a number of other risk factors, particularly an increased body mass index (BMI).
Methods
The study was approved by and conducted under the guidelines of the Ethics Committee of the Alfred Hospital. Informed consent was obtained prior to enrolment in the study.
Recruitment CHD cases and controls were recruited from attendees at health screening clinics operated by the Baker Medical Research Institute and the Anticancer Council of Victoria. Subjects attending these clinics were invited to complete a 'chest pain' questionnaire. This questionnaire firstly identified subjects who were aware of a previous diagnosis of myocardial infarction or angina. Such subjects were not eligible to participate in the study. The remaining subjects were then requested to complete the remainder of the questionnaire, which established whether they experienced chest=jaw=arm pain, whether this was exertional in origin, whether it was relieved by rest or had other clearly identified provoking or relieving features. They also marked the location of the pain on a cartoon torso. Completed questionnaires were then evaluated by a medical officer. Subjects whose responses indicated a possible cardiac origin for their symptoms were then invited to attend for an ECG stress test using a modified Bruce protocol. Positivity during the stress test was identified as a ! 2 mm ST segment depression. CHD cases identified on the basis of their response to the questionnaire and a positive stress test were considered to have angina that had been previously unrecognized and in most cases was of recent onset. The objective of this recruitment strategy was to identify CHD cases before they had received specific medication or had made lifestyle changes in response to their diagnosis. Although not part of the recruitment process, 25 of the CHD cases subsequently underwent coronary angiography as part of their routine clinical management. Of these, 22 were found to have at least one angiographic stenosis of at least 50%. The remaining three patients (all female) had coronary irregularities but no angiographic stenosis greater than 50%.
Three matched control subjects were recruited for each case from the same source as the respective case. Control subjects had responded negatively in the questionnaire to the presence of exertional chest pain and had no history of angina or myocardial infarction. Control subjects did not undergo an exercise ECG evaluation. The current report focuses on results from fasting blood samples taken within days of the identification of angina in the CHD subjects and before the institution of specific therapy other than nitrates. However, hypertensive subjects did continue with pre-existing medications. Height, weight and sitting blood pressure, measured by brachial artery sphygmomanometry, were measured at the time of blood sampling.
Participants subsequently completed a socio-economic status questionnaire containing questions on their level of education (in five categories), their maximum household income (five bands) and their employment history (seven categories).
Biochemical analyses
Analysis of plasma lipids and lipoprotein fractions was conducted on a COBAS Bio centrifugal autoanalyser (Roche). Glucose analyses were performed on a Kodak Ektachem DT 60 analyser and insulin concentrations determined by an immunoassay (Abbott Imx) with no cross-reactivity with pro-insulin ( < 0.005%).
LDL particle diameters were determined on 3 -13% nondenaturing gradient gels following isolation of LDL by ultra centrifugation. 6 LDL peak sizes were estimated against a standard curve created from markers of known diameter. The diameter of the most prevalent LDL subclass was then used in subsequent analyses.
Euglobulin lysis times and plasma levels of von Willebrand Factor (vWF) were determined on platelet poor plasma as previously described 10 in a sub-set of the cohort.
Chlamydia immunofluorescence
Serum was collected from all subjects and tested for the presence of antibodies to Chlamydia pneumoniae using the Savyon Chlamydia IgG SeroFIA TM and IgM SeroFIA TM test kits (DADE Behring, Savyon Diagnostics, Israel). SeroFIA TM uses antigen purified from C. pneumoniae (TW-183), C. trachomatis (L2) and C. psittaci (SZ-1) and is a solid-phase immunofluorescent assay performed on a 21-well antigencoated glass slide. Each reaction slide contains three rows of seven wells, each row containing C. pneumonia, C. trachomatis or C. psittaci antigen. This allows for the detection of specific IgG or IgM antibodies to C. pneumonia, C. trachomatis or C. psittaci.
Each serum sample was tested for specific antibodies against each of the three Chlamydia species. Briefly, patient sera was diluted to 1:64 and placed over the respective antigens in each row. Following incubation the slides were washed to remove any unbound serum components. Fluorescein-conjugated anti-human IgG or IgM was then added to each well. After incubation and a further washing step, the slides were dried and coverslips mounted. Examination of the slides using fluorescence microscopy allowed positive sera, which appeared as bright apple-green fluorescent EBs against a dark background, and negative sera, which exhibited no, or faint background, fluorescence, to be determined. To validate results, positive and negative control sera were included in each test run.
Positive test sera were graded as strongly positive, where moderate to intense sharp or diffuse apple-green Chlamydia and body mass index AM Dart et al fluorescence was detected. Alternatively, where definite but dim fluorescence was detected, sera were considered to be at the end-point titre of detection (1 : 64). Each slide was examined independently by two observers. There was 100% agreement between these independent classifications. 
Statistics

Results
Complete biochemical and chlamydiae data were available for 170 subjects (43 CHD and 127 control) of whom 63% were male. The average age of the participants was 62.5 AE 0.4 y. Comparison of the CHD and control groups showed a significantly higher prevalence of blood pressure treatment in the CHD group as well as elevated fasting insulin (Table 1 ). Other differences between the groups were not significant (Table 1) . Sixty-two of the 170 subjects were positive (20 strongly) for IgG immunofluoresence to C. pneumoniae, whilst no subjects were positive for IgM. There were, however, no differences in positivity between CHD cases and controls (Table 1 ) and this was also the case in the subgroup of 22 CHD cases who subsequently underwent angiography on clinical grounds and were identified as having > 50% coronary narrowing. Similarly there was no increased prevalence if positivity was analysed separately for strongly positive immunofluorescence (7% for all CHD cases vs 13% for controls). Four of the 170 subjects were positive for IgG immunofluoresence to C. trachomatis (three) and=or C. psittacci (two).
There were significant differences in BMI and LDL particle size between subjects positive or negative for IgG immunofluorescence to C. pneumoniae (Table 2 ). IgG serum positivity was not significantly different between subjects identified as hypertensive (blood pressure > 160=90 mmHg or receiving blood pressure treatment) and normotensive subjects (44.0 vs 35.1%). However, males (42.8%) had a significantly higher positivity than females (26.1%, P ¼ 0.03). Subjects were divided into those above and below the median values for fasting insulin, LDL diameter and BMI. Those above the median of the insulin distribution and below the median of LDL diameter distribution had significantly higher positivity (Table 3) . Differences failed to reach statistical significance for BMI (P ¼ 0.073). However comparison of the top quartile with the remaining subjects for BMI revealed positivity for 49 vs 29% (P ¼ 0.046).
In a multivariate analysis including BMI, insulin and LDL diameter as dependent variables and gender and positive IgG immunofluorescence to C. pneumoniae as factors, only BMI was significantly different between IgG positive and negative groups (P ¼ 0.04). LDL diameter (P ¼ 0.037) but not insulin or BMI were significantly dependent on gender. There were no significant interactions between IgG positivity and gender for any of the three variables (P > 0.2 for all).
Subjects were categorised on the basis of their household income (more or less than AU$50 000 per annum), their highest level of education (attended university or technical Chlamydia and body mass index AM Dart et al college vs did not attend) and their employment history (employed in a professional or managerial capacity vs not so employed). Neither BMI nor past history of infection were significantly related to any of these measures of socio-economic status. Twenty-one percent of those both below and above the median BMI reported a household income of > $50 000, 53% above and 48% (P ¼ 0.86) below the median of BMI reported professional or managerial employment whilst 37% below and 25% (P ¼ 0.14) above the BMI median reported a university or technical college education. The respective rates of past infection with C. pneumoniae were 42 vs 35% (P ¼ 0.42) for those with income > $50 000 compared with income < $50 000, 43 vs 31% (P ¼ 0.23) for those with professional or managerial employment history compared with those otherwise employed and 40 vs 35% (P ¼ 0.51) for those who had received university or college education compared with those who had not. Data were available on a subset of subjects for examining the relationship between evidence of previous exposure to C. pneumoniae and vWF (n ¼ 88) and euglobulin lysis time 
Discussion
The current study identifies male sex, an increased BMI, small LDL particles and elevated fasting insulin as factors associated with positive IgG immunofluorescence to C. pneumoniae. In multivariate analysis, only the effects of BMI remained significant. Although vWF and global measures of fibrinolysis have been associated with CHD, 10, 11 neither showed any association with Chlamydiae infection in the current study. There was also no evidence for an increased prevalence of seropositivity in CHD subjects identified on the basis of chest pain and a positive exercise test. A sub-set of patients subsequently underwent coronary angiography as part of their medical management and 88% of these were found to have significant coronary artery stenoses. There was no evidence of increased seropositivity if analysis was restricted to angiographically positive cases.
Whilst a number of previous studies have observed an increase in IgG seropositivity in CHD subjects negative studies have also been reported. 12 The recruitment strategy specifically sought CHD patients with a recent onset of symptoms since we were particularly interested in minimising the potential effects of dietary, lifestyle and medication changes on CHD risk factors. It is therefore interesting that none of the CHD cases were seropositive for IgM that would have been indicative of infection around the time of their onset of chest pain.
A previous study has found an increased prevalence of seropositivity amongst subjects with severe hypertension. 9 Although there was increased prevalence amongst those subjects diagnosed as having hypertension on the basis of their prevailing blood pressure levels or the presence of treatment, this was not significant. However, none of our subjects were classified as being severely hypertensive. There was no association in the present study between vWF and Chlamydia infection in keeping with other studies 9,13 one of which failed to find a relation with insulin resistance. 13 An earlier study has reported an association between high titres to C. pneumoniae and total cholesterol and triglyceride concentrations. 8 There are three possible explanations for the finding of associations between BMI, small LDL particles, fasting insulin and IgG positivity to C. pneumoniae. There may be no causal relationship responsible for these findings. Infection with C. pneumoniae may be related causally to the production of hyperinsulinaemia and increased BMI. A third possibility is that increased BMI, hyperinsulinaemia and male gender themselves, individually or in combination, predispose towards chlamydial infection. As indicated in multivariate analysis most of the association can be attributed to higher BMI. The consequent hyperinsulinaemia and small LDL particle size could thus be explained as being secondary to the increase in weight. It is possible that a predisposition to respiratory infections may occur with increasing BMI and contribute to the association documented in this study. Thus overweight preadolescent children have been shown to be more susceptible to respiratory infections.
14 Increased BMI has also been associated with impaired immunity. 15 However only approximately 10% of the total cohort had a BMI greater than 30 kg=m 2 and it is not clear whether lesser degrees of increased weight would also be associated with increased prevalence of respiratory infections and impaired immunity. In addition it should be noted that positive serology to other Chlamydia species was extremely low in the total cohort. Differences in socio-economic status could theoretically account for relations between evidence of past Chlamydia infection and body weight. Thus if body weight and infection were both dependent on socio-economic status there could be a statistical relation between these parameters even in the absence of any causal relationship. In an effort to explore this possibility we arranged for subjects to complete a socio-economic questionnaire. However there was no evidence within this population of a contribution from differences in socio-economic status.
Although in this study there was no association between the evidence of chlamydial infection and CHD, the associations documented with BMI, insulin and male gender may themselves contribute to other documented associations between chlamydial infection and CHD. Another likely mutual risk factor is cigarette smoking, and Chlamydia immune complexes have previously been related to cigarette smoking. 7 In this study, cigarette smoking was only present in two CHD cases and two control subjects, making an examination of this issue impossible. The low prevalence of cigarette smoking may indicate a more health-conscious attitude among these self-referred subjects than is generally present in the community. The overall prevalence of IgG Chlamydia and body mass index AM Dart et al seropositivity was somewhat lower (36%) in this study than in a randomly selected urban population in Australia (58%), 16 which may reflect such an effect. In conclusion, the results of this study indicate that previous exposure to C. pneumoniae is associated with a number of CHD risk factors including those of the 'metabolic syndrome'. An increase in BMI appears to underlie these associations.
